-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Outperform on Black Diamond Therapeutic, Raises Price Target to $14

Benzinga·03/17/2026 12:35:52
Listen to the news
Wedbush analyst Robert Driscoll maintains Black Diamond Therapeutic (NASDAQ:BDTX) with a Outperform and raises the price target from $13 to $14.